Tumor-specific MHC-II expression drives a unique pattern of resistance to immunotherapy via LAG-3/FCRL6 engagementDouglas B. Johnson, Justin M. Balko, Roberto Salgado et al.|JCI Insight|2018Cited by 162
MEK activation modulates glycolysis and supports suppressive myeloid cells in TNBCDerek A. Franklin, Justin M. Balko, Joe T. Sharick et al.|JCI Insight|2020Cited by 50
Abstract 1511: MEK activation modulates immunosuppressive MDSCs and metabolic phenotypes in TNBCDerek A. Franklin, Justin M. Balko, Joe T. Sharick et al.|Cancer Research|2019Cited by 0
Abstract 1511: MEK activation modulates immunosuppressive MDSCs and metabolic phenotypes in TNBCDerek A. Franklin, Justin M. Balko, Joe T. Sharick et al.|Immunology|2019Cited by 0